These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6342656)

  • 41. Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation.
    Atkinson K; Biggs JC; Ting A; Concannon AJ; Dodds AJ; Pun A
    Br J Haematol; 1983 Feb; 53(2):265-70. PubMed ID: 6336949
    [No Abstract]   [Full Text] [Related]  

  • 42. [Optimal dose of cyclosporin in living related kidney transplantation].
    Tanabe K; Takahashi K; Sonda K; Yagisawa T; Oba S; Nakazawa H; Goya N; Yamaguchi Y; Fuchinoue S; Nakamura M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):528-35. PubMed ID: 1593833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal function and blood pressure in psoriatic patients treated with cyclosporin A.
    Feutren G; Abeywickrama K; Friend D; von Graffenried B
    Br J Dermatol; 1990 Jun; 122 Suppl 36():57-69. PubMed ID: 2196085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study.
    Sobh M; el-Agroudy A; Moustafa F; Harras F; el-Bedewy M; Ghoneim M
    Am J Nephrol; 1995; 15(6):493-9. PubMed ID: 8546171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
    Doney K; Leisenring W; Storb R; Appelbaum FR
    Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
    Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE
    S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporin in renal transplantation: a 9 year experience.
    Yuan ZF; Bailey RR; Gardner J
    N Z Med J; 1995 Feb; 108(993):29-32. PubMed ID: 7891931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low dose cyclosporine in rheumatoid arthritis: a pilot study.
    Tugwell P; Bombardier C; Gent M; Bennett K; Ludwin D; Grace E; Buchanan WW; Bensen WG; Bellamy N; Murphy GF
    J Rheumatol; 1987 Dec; 14(6):1108-14. PubMed ID: 3437417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
    Stockschlaeder M; Storb R; Pepe M; Longton G; McDonald G; Anasetti C; Appelbaum F; Doney K; Martin P; Sullivan K
    Br J Haematol; 1992 Jan; 80(1):49-54. PubMed ID: 1536809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of immunosuppression by serum inhibition of alloreaction and measurement of cyclosporin A (CyA) serum levels in kidney graft recipients under CyA.
    Chabannes D; Vernillet L; Cantarovich D; Humbert H; Vie H; Soulillou JP
    Transpl Int; 1990 Dec; 3(4):189-94. PubMed ID: 2076168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dermatological aspects of the use of Cyclosporin A for prophylaxis of graft-versus-host disease.
    Harper JI; Kendra JR; Desai S; Staughton RC; Barrett AJ; Hobbs JR
    Br J Dermatol; 1984 Apr; 110(4):469-74. PubMed ID: 6370294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fractional excretion of sodium represents an index of cyclosporine nephrotoxicity in the early post-transplant period.
    Morales JM; Andres A; Prieto C; Ruilope LM; Alcazar JM; Oliet A; Praga M; Rodicio JL
    Transplant Proc; 1987 Oct; 19(5):4005-7. PubMed ID: 3313985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term use of cyclosporin in liver grafting.
    Williams R; Blackburn A; Neuberger J; Calne RY
    Q J Med; 1985 Dec; 57(224):897-905. PubMed ID: 3912795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal side-effects of cyclosporin A with special reference to autoimmune diseases.
    Mihatsch MJ; Thiel G; Ryffel B
    Br J Dermatol; 1990 Jun; 122 Suppl 36():101-15. PubMed ID: 2196077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.
    Shulman H; Striker G; Deeg HJ; Kennedy M; Storb R; Thomas ED
    N Engl J Med; 1981 Dec; 305(23):1392-5. PubMed ID: 7029278
    [No Abstract]   [Full Text] [Related]  

  • 57. [How long should cyclosporin be administered following bone marrow transplantation?].
    Gratwohl A; Tichelli A; Stauffer G; Passweg J; Pless M; Gengenbacher D; Buser U; Signer E; Haberthür C; Gimmi C
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):44-50. PubMed ID: 8296190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of cyclosporine dosage and plasma levels in efficacy and toxicity in bone marrow transplant recipients.
    Lindholm A; Ringdén O; Lönnqvist B
    Transplantation; 1987 May; 43(5):680-4. PubMed ID: 3554661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nephrotoxicity of iopamidol in pediatric, adolescent, and young adult patients who have undergone allogeneic bone marrow transplantation.
    Haight AE; Kaste SC; Goloubeva OG; Xiong XP; Bowman LC
    Radiology; 2003 Feb; 226(2):399-404. PubMed ID: 12563132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Low early mortality after allogeneic bone marrow transplantation thanks to rigorous sterility measures, modified whole body irradiation, cyclosporin A and antiviral precautions].
    Gmür J; Burger J; Frick P
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1524-5. PubMed ID: 3001930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.